Acuitas: noun, insight, perception, sharpness.

Ying K. Tam Ph.D. Director Preclinical Research

Ying-Tam-headshotDr. Tam obtained his BSc. and Ph.D. in Biology from the University of Waterloo, Ontario. He has held senior academic and industry positions including Instructor and Assistant Professor in the Department of Hematology/Oncology in the Faculty of Medicine, Rush-Presbyterian-St. Luke’s Medical Center in Chicago, IL, USA and Senior Scientist at Tekmira Pharmaceuticals before joining Acuitas. He has extensive experience in a wide range of preclinical studies with particular focus on immunology and immunotherapy. In both academic and industry positions he has lead research teams developing novel liposomal immunotherapy agents.

Dr. Tam has strong practical experienced in the design and conduct of preclinical studies including safety, pharmacodynamic and pharmacokinetic studies. As a Senior Research Scientist at Tekmira Pharmaceuticals he oversaw the conduct of preclinical studies relating to development of immune-stimulating liposomal oligonucleotide products. Dr. Tam is an author on over 45 published or submitted scientific manuscripts.

Our History

Acuitas Therapeutics is a private company incorporated in British Columbia, Canada. We were founded in February 2009 (initially as AlCana Technologies) and have partnered with Alnylam Pharmaceuticals, the University of British Columbia, IRAP and others on several research and development programs relating to systemic delivery of nucleic acid therapeutics.
Contact Information

Twitter Feed

Find out what's happening, right now, with Acuitas Therapeutics.


Copyright 2018 Acuitas Therapeutics. Web Design by Tommy Le Inc.